AstraZeneca has entered a partnership with Oracle aimed at using artificial intelligence to improve clinical research processes. The deal adds to a growing list of AI collaborations within the pharmaceutical industry.
wsj.com
· 2026-10-20
AstraZeneca has agreed to pay AI-driven biotech company Insitro $40 million upfront, with potential milestone payments bringing the total deal value to as much as $1.46 billion. The partnership centers on using Insitro's machine learning platform for drug discovery.
wsj.com
· 2026-10-15
AstraZeneca has agreed to invest $2 billion in Summit Therapeutics as part of an expanded partnership to develop cancer treatments. Summit's shares jumped in after-hours trading following the announcement.
wsj.com
· 2026-09-28